Diabetes plays key role in the emergence and expansion of antibiotic resistance

Antibiotics are powerful, fast-acting medications designed to eradicate bacterial infections. However, in recent years, their dependability has waned...

NIH researchers define topical steroid withdrawal diagnostic criteria

Researchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid withdrawal (TSW)...

Psychosomatic Allergy: How Stress Influences the Immune System

The intricate relationship between psychological stress and allergic reactions represents one of the most fascinating frontiers in modern...

Single dose of antibody shields macaques from severe H5N1 influenza

National Institutes of Health (NIH) scientists and their colleagues report that a single dose of a broadly neutralizing...

How your diet and probiotics can improve vaccine effectiveness

Could your gut bacteria decide how well vaccines work? A new study reveals how diet and probiotics could...

Omalizumab outperforms oral immunotherapy in treating multi-food allergy

A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than...

Eating a variety of plants helps infants build a stronger gut microbiome

New research reveals that infants who eat a greater variety of plant foods develop a more mature gut...

New therapeutic cocktails show promise for long-lasting asthma relief

Current asthma treatments don't work in all patients, and they don't provide long-term relief from potentially deadly asthma...

Children with peanut allergy achieve tolerance with gradual peanut butter ingestion

Eating gradually increasing doses of store-bought, home-measured peanut butter for about 18 months enabled 100% of children with...

Scientists develop promising new drug candidates against coronaviruses

A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise...

Tecovirimat monotherapy found ineffective for treating clade II mpox in NIH-sponsored trial

NIH-sponsored trial data offer further evidence to help inform mpox treatment decisions. Colorized transmission electron micrograph of immature...

Study reveals key insights for preventing cytomegalovirus spread to fetuses

A new Weill Cornell Medicine and Oregon Health & Science University co-authored study provides critical insight for the...

Neuroimmune Mechanisms of Allergic Diseases and Depression: From Cytokine Cascade to Clinical Treatment Protocols

The relationship between allergic diseases and depression extends far beyond simple comorbidity, representing a fundamental neurobiological connection mediated...

New antibiotic offers hope for more effective Lyme disease treatment

Lyme disease, a disease transmitted when deer ticks feed on infected animals like deer and rodents, and then...

Daily peanut doses help adults overcome severe allergies

The first clinical trial to test whether adults allergic to peanuts can be desensitized has shown great success...

Research links high pollen exposure to increased death rates in older adults

As climate change intensifies pollen seasons across the country, new research from the University of Michigan reveals a...

Influenza A virus changes shape to evade immune responses

Influenza A virus particles strategically adapt their shape-to become either spheres or larger filaments-to favor their ability to...

New nasal vaccine for COVID-19 set to begin clinical trial in the U.S.

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is...

Machine learning algorithm decodes immune system’s hidden data for disease detection

Your immune system harbors a lifetime's worth of information about threats it's encountered - a biological Rolodex of...

Material from nasal lavage provides a basis for assessing COPD

Early diagnosis of COPD, chronic obstructive pulmonary disease, increases the quality of life of the patient and the...

Early gut microbiota linked to food sensitivities in infants

A study led by Hiroshi Ohno at the RIKEN Center for Integrative Medical Sciences (IMS) recently showed that certain gut bacteria found in one-month-old infants are associated with food sensitivities and the development of food allergies, particularly to eggs, while other types of bacteria are not. The study also found factors that predicted which type of bacteria would be present in the guts of newly born babies. Together, the findings suggest that certain probiotic supplements might be a good early defense for preventing food allergies, especially for at-risk infants. The study was published in the Journal of Allergy and Clinical Immunology.

Microbiota present in the gut soon after birth, which include bacteria, are known to help with normal development of the immune system and even protect against some diseases. However, research into the link between gut microbiota and food sensitivities and food allergies has produced mixed results. The new study tackled this problem by analyzing gut bacteria data from two separate groups of Japanese children for seven years, starting from birth. One was a high-risk group of 270 children from families with histories of allergies. The other was a group of 245 children from a previous study designed to test allergy treatments.

Food allergies happen when the body mistakes a protein in the food as dangerous and mounts an immune response to attack it. This immune response is in the form of the antibody called immunoglobulin E, or IgE for short, which comes in a number of varieties depending on the trouble-making food protein. The study looked at milk-, peanut-, egg white-, and wheat-specific IgE levels in the blood from one year after birth until the children were seven years old. At the same time, gut microbiota data were also collected, starting from one week after birth. By analyzing both, the team hoped to find predictable gut microbiota biomarkers for food sensitization and allergies.

The first finding was that of all the time points over the seven-year period, gut microbiota present one month after birth were the most related to the food-specific IgE levels in the blood, even when the children were seven years old. "We know that the early neonatal period is critical for immune system development," says Ohno, "and our results emphasize this, showing that the type of bacteria in the gut at this critical time is the best at predicting immune responses to food seven years down the road."

The analysis segregated microbiota into groups that changed over time. Focusing on the three types of bacteria that dominated the infant microbiomes one month after birth, the researchers found that babies with type-3, Bifidobacterium-dominant, microbiomes were significantly less likely to develop food sensitization to egg whites than were babies who had microbiomes that were dominated by one of the other categories of bacteria. This was also the trend for allergic reactions to egg whites later in life.

So, what determines which kind of bacteria an infant has one month after birth? To answer this question, researchers looked at other data available for the 515 children. They found that the type of delivery and the amount of breast feeding were linked to the gut microbiota. Infants who were delivered normally and received relatively less breast feeding turned out to be in the best shape, having type-3, Bifidobacterium-dominant microbiomes. Type-1 microbiota dominated when births were normal, but breast feeding was high, while type-2 microbiota dominated when delivery required a Cesarian section and the amount of breast feeding was low.

We conducted this study in the hope that a better understanding of neonatal gut microbiota would help generate ideas for allergy prevention strategies. We found that these microbiota do correlate with food allergens-specific serum IgE levels, and that intervention with Bifidobacterium during infancy might help prevent later food allergies, especially in infants who are the most at risk."

Hiroshi Ohno, RIKEN Center for Integrative Medical Sciences

 

Source:

RIKEN

Journal reference:

Shibata, R., et al. (2024). Neonatal gut microbiota and risk of developing food sensitization and allergy. Journal of Allergy and Clinical Immunology. doi.org/10.1016/j.jaci.2024.10.029.


Source: http://www.news-medical.net/news/20250221/Early-gut-microbiota-linked-to-food-sensitivities-in-infants.aspx

Inline Feedbacks
View all comments
guest